Court Rejects AstraZeneca’s Challenge to Inflation Reduction Act
TL/DR -
A US federal court in Delaware ruled against AstraZeneca's challenge to the Medicare drug price negotiation provisions of the Inflation Reduction Act. The court determined that the pharmaceutical company had no legitimate claim of entitlement to sell its drugs to the Government at a price other than what the Government is willing to pay.…